Previous studies have reported that IER3 is involved in the activation of the PI3 K/AKT and MAPK/ERK signaling pathways [32], which promotes tumor progression, also suggesting that IER3 plays a role in promoting tongue cancer, but further in vivo evidence is needed. This evidence concerns the gene AKT1 and tongue cancer.